BioSqueeze Inc. (BZS) announced it had raised $7.4 million from investors, including Next Frontier Capital, Riverstone LLC, and Valo Ventures to upgrade existing technology.

BioSqueeze Inc., based in Butte, Montana, is the global market leader in commercial biomineralization. BioSqueeze is a fluid-based biotechnology that plugs tiny leakage channels in oil and gas wells. BioSqueeze creates a crystalline calcium carbonate barrier that, like limestone, removes sustained casing pressure (SCP) and inhibits fugitive greenhouse gas emissions (GHG).

The new investment will enable BioSqueeze to lead the industry's methane reduction initiatives and meet the rising demand for the company's natural biomineralization technology. By expanding its fleet of mobile leak-sealing vehicles, implementing real-time, remote operations from its Butte headquarters, and developing new products in rigless deployment, enhanced oil recovery, soil stabilisation, and infrastructure repair, the company will accelerate its growth across North America.

Since the release of this technology, which has been implemented successfully in hundreds of facilities in the US, information about the benefits of using this technology continues to spread through word-of-mouth by companies interested in reducing their CO2 footprint and investors who want to protect investor returns on their investments.
"Our technology gives the oil and gas industry a much-needed tool for decreasing methane emissions," said Mark Ranalli, President and CEO of BioSqueeze. "Recent events have demonstrated the importance of clean and reliable energy to society and the environment. With the industry raising the standard for identifying and remediating fugitive emission sources, our natural technology guarantees leaks are sealed efficiently and cost-effectively to maximise the impact of the investment."